Literature DB >> 22438506

Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec.

Helen Cerigo1, François Coutlée, Eduardo L Franco, Paul Brassard.   

Abstract

OBJECTIVE: To assess the comparability of self-collected cervicovaginal samples and provider-collected cervical samples for the detection of human papillomavirus (HPV) DNA among Inuit women in Nunavik, Quebec, avoiding the use of liquid-based storage and transport of the self-collected samples.
METHODS: Ninety-three women aged 18-69 years were recruited from a previously formed cohort on the natural history of HPV to this cross-sectional measurement study. This study utilized HPV DNA test results from 89 paired specimens collected by study participant and health provider with Dacron swabs. Samples were tested for 36 HPV types with the PGMY-primer PCR protocol and genotyping with the linear array method. Unweighted kappa statistics and McNemar tests were used to measure the agreement between sampling techniques.
RESULTS: In the self-collected samples, 30 different HPV types were found, compared with 29 types found in the provider-collected samples. The prevalence of high-risk (HR) HPV was 38.2% in the self-collected samples and 28.1% in the provider-collected samples. The agreement between collection methods for the detection of HR-HPV DNA (85.4%) was good. HR-HPV and type-specific HPV 16/18 were as likely to be detected in the self-collected samples compared with the provider-obtained samples.
CONCLUSIONS: Women in this population were easily able to collect adequate cervicovaginal specimens for HPV testing. As self-sampling has a high recovery of HR-HPV and is comparable with provider-sampling, we conclude that self-sampling with dry storage and transport could be a good cervical cancer screening alternative for Inuit women in Nunavik who have traditionally avoided speculum examination.

Entities:  

Mesh:

Year:  2012        PMID: 22438506     DOI: 10.1258/jms.2012.012011

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  13 in total

Review 1.  Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians.

Authors:  M Saraiya; M Steben; M Watson; L Markowitz
Journal:  Prev Med       Date:  2013-02-08       Impact factor: 4.018

2.  Vaccination of Young Women Decreases Human Papillomavirus Transmission in Heterosexual Couples: Findings from the HITCH Cohort Study.

Authors:  Michel D Wissing; Ann N Burchell; Mariam El-Zein; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-05       Impact factor: 4.254

3.  Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.

Authors:  Eliane Rohner; Claire Edelman; Busola Sanusi; John W Schmitt; Anna Baker; Kirsty Chesko; Brian Faherty; Sean M Gregory; LaHoma S Romocki; Vijay Sivaraman; Julie A E Nelson; Siobhan O'Connor; Michael G Hudgens; Andrea K Knittel; Lisa Rahangdale; Jennifer S Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-17       Impact factor: 4.254

4.  Using community engagement to inform and implement a community-randomized controlled trial in the anishinaabek cervical cancer screening study.

Authors:  Brianne Wood; Ann N Burchell; Nicholas Escott; Julian Little; Marion Maar; Gina Ogilvie; Alberto Severini; Lisa Bishop; Kyla Morrisseau; Ingeborg Zehbe
Journal:  Front Oncol       Date:  2014-02-19       Impact factor: 6.244

5.  Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test.

Authors:  Chun-Qing Lin; Xi Zeng; Jian-Feng Cui; Guang-Dong Liao; Ze-Ni Wu; Qian-Qian Gao; Xun Zhang; Xiu-Zhang Yu; Wen Chen; Ming-Rong Xi; You-Lin Qiao
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

Review 6.  The acceptability of vaginal smear self-collection for screening for cervical cancer: a systematic review.

Authors:  Natalia Serrano Doratioto Faria Braz; Noely Paula Cristina Lorenzi; Isabel Cristina Esposito Sorpreso; Lana Maria de Aguiar; Edmund Chada Baracat; José Maria Soares-Júnior
Journal:  Clinics (Sao Paulo)       Date:  2017-03       Impact factor: 2.365

7.  Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening.

Authors:  Ditte Møller Ejegod; Helle Pedersen; Garazi Peña Alzua; Camilla Pedersen; Jesper Bonde
Journal:  Papillomavirus Res       Date:  2018-04-22

8.  Randomized comparison of vaginal self-sampling by standard vs. dry swabs for human papillomavirus testing.

Authors:  Isabelle Eperon; Pierre Vassilakos; Isabelle Navarria; Pierre-Alain Menoud; Aude Gauthier; Jean-Claude Pache; Michel Boulvain; Sarah Untiet; Patrick Petignat
Journal:  BMC Cancer       Date:  2013-07-22       Impact factor: 4.430

9.  Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial.

Authors:  K Haguenoer; S Sengchanh; C Gaudy-Graffin; J Boyard; R Fontenay; H Marret; A Goudeau; N Pigneaux de Laroche; E Rusch; B Giraudeau
Journal:  Br J Cancer       Date:  2014-09-23       Impact factor: 7.640

10.  Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid.

Authors:  Geert A A Van Raemdonck; Wiebren A A Tjalma; Edmond P Coen; Christophe E Depuydt; Xaveer W M Van Ostade
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.